A new vaccine - which targets proteins involved in the most common cause of dementia - offers ‘fresh hope’ for scientists
Six in ten under-30s have had a first dose as drop-in jabs continue at Moulton Park centre
More from us
Did you know with an ad-lite subscription to Northamptonshire Telegraph, you get 70% fewer ads while viewing the news that matters to you.